Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study in Comorbid Patients With Chronic Lymphocytic Leukemia Receiving First-line Bendamustine With Rituximab

NCT02381899 is registered in ClinicalTrials.gov with Czech CLL Study Group as lead sponsor.

NCT NCT02381899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02381899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study in Comorbid Patients With Chronic Lymphocytic Leukemia Receiving First-line Bendamustine With Rituximab
Lead sponsor
Czech CLL Study Group
Phase
Observational
Overall status
Completed
Start date
September 30, 2014
Completion date
December 31, 2018
Enrollment
83 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia